• Multiple Myeloma
• Lymphoma

Clinically, Dr Hoffmann has a subspecialty clinic at a tertiary academic medical center specializing in the management of lymphoma and CLL patients. In addition to inpatient responsibilities, he sees approximately 70 unique outpatients per week with these diseases and manage their work-up, therapy and post-treatment surveillance. He gives grand rounds, continuing nursing education, and continuing medical education lectures locally and nationally concerning management of CLL and lymphoma.

Dr Hoffmann serves as the local principal investigator on all of our indolent non-Hodgkin lymphoma and CLL clinical trials. He is chair of our disease working group for lymphoma and myeloma that presents and subsequently votes on all clinical trials that open at our site. He is on the SWOG lymphoma subcommittee and assists with design and implementation of cooperative group trials in this domain.

Additionally, he serves as a medical director for quality within the cancer center. In this role, he has led multiple improvement projects and helps to manage the Cancer Center service line value stream. Selected projects include improving efficiency with infusion suites, development and rollout of home infusion services for cancer patients, and designing an oral chemotherapy process to optimize patient safety. This work has been presented at national and regional meetings.